After deferring its decision on whether to approve a controversial new muscular dystrophy drug, the FDA will allow drug companies to charge patients for the manufacturing cost of experimental treatments used under compassionate grounds.
Supply Chain
Autopsy results released last Thursday indicate that Prince Rogers Nelson, the musician commonly known as Prince, died from an accidental overdose of fentanyl.
The results of an exploratory clinical trial indicate that a wearable artificial kidney could serve as a viable new dialysis technology.
In the past decade, more and more shareholders have pushed pharmaceutical firms to focus solely on drug production, causing companies like Pfizer and Merck to sell their consumer goods businesses. However, Johnson & Johnson continues to ignore this trend.
Mundelein, Ill.-based Medline was awarded the Seller of the Year award by Vizient, the largest member-owned healthcare company in the U.S. The award honors Medline for showing continuous commitment to improving healthcare supply chain innovation through its research and ideas,…
Advertisement
Yesterday, the FDA approved a medical device terminally sterilized by Noxilizer's nitrogen dioxide sterilization process.
The FDA created the Expedited Access Pathway program last year to facilitate the development and access of new medical technology for patients suffering from life-threatening illnesses.
Salutaris Medical Devices is one of the top 10 finalists for the spring 2016 round of the Arizona Innovation Challenge, a competitive grant program sponsored by the Arizona Commerce Authority, according to Arizona Daily Star.
Medical device company OtoNexus is developing and commercializing a device that uses Doppler ultrasound to provide more accurate diagnoses of middle ear infections.
On Wednesday, Florida health officials changed the state's policy for administering expensive hepatitis C drugs to Medicaid patients, now requiring insurance companies to provide the drug at an earlier stage of the disease.